Robert Azelby Insider Trading for February 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Robert Azelby.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Robert Azelby for February 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 14 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Sell | S | 85.55 | 4,157 | 355,631 | 89,614 | 93.8 K to 89.6 K (-4.43 %) |
| Feb 09 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Option Exercise | M | 20.76 | 2,663 | 55,284 | 98,545 | |
| Feb 09 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Option Exercise | M | 25.29 | 834 | 21,092 | 30,002 | |
| Feb 09 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Sell | S | 85.77 | 3,497 | 299,938 | 93,771 | 97.3 K to 93.8 K (-3.60 %) |
| Feb 09 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Buy | M | 20.76 | 2,663 | 55,284 | 97,268 | 94.6 K to 97.3 K (+2.81 %) |
| Feb 09 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Buy | M | 25.29 | 834 | 21,092 | 94,605 | 93.8 K to 94.6 K (+0.89 %) |
| Feb 09 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Payment of Exercise | F | 85.49 | 2,700 | 230,823 | 93,771 | 96.5 K to 93.8 K (-2.80 %) |
| Feb 02 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Option Exercise | M | 51.76 | 4,167 | 215,684 | 93,294 | |
| Feb 02 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Sell | S | 85.78 | 4,167 | 357,445 | 96,471 | 100.6 K to 96.5 K (-4.14 %) |
| Feb 02 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Buy | M | 51.76 | 4,167 | 215,684 | 100,638 | 96.5 K to 100.6 K (+4.32 %) |
| Feb 02 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Grant | A | 0.00 | 25,639 | 0 | 96,471 | 70.8 K to 96.5 K (+36.20 %) |